InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by KING STEVEN W, Director. Officer active across 1 companies, notably Oncotelic Therapeutics, Inc.. Aggregated, 2 reports have been published. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
3,291,720 shares
Common Stock
SEC:0001493152-21-017105·
3,291,720 shares
Common Stock
SEC:0001493152-21-017105:0·
2 of 2 declarations
About KING STEVEN W
Steven W. King is a Director at Oncotelic Therapeutics, Inc. As a board member, he plays a key role in the governance of the company, providing his expertise and strategic advice. Steven is involved in making important decisions that influence the direction of Oncotelic, contributing to its development and growth in the biopharmaceutical sector. His diverse experience enriches discussions within the board.
